New resource designed to help prevent CINV



Cancer patient
receiving chemotherapy
Photo by Rhoda Baer
The Hematology/Oncology Pharmacy Association (HOPA) has announced the release of a toolkit intended to help prevent chemotherapy-induced nausea and vomiting (CINV) in cancer patients. The Time to Talk CINV™ toolkit was designed to facilitate dialogue between patients and their healthcare teams to ensure no... [Read Article]

Cancer survivors report pros and cons of telehealth



doc-female-cell_daniel-sone-nci_220.jpg
Doctor using a smartphone
Photo by Daniel Sone
Cancer survivors report a range of benefits and detriments related to telehealth, according to research published in the Journal of Medical Internet Research. Telehealth is the use of technology to provide remote, personalized healthcare to patients. Telehealth services allow patients to have meetings and follow-up... [Read Article]

Kids, parents over-report ALL treatment adherence



prescription_pills_240.jpg
Prescription pills

New research published in Blood suggests young patients with acute lymphoblastic leukemia (ALL)—and their parents—are likely to over-report treatment adherence. In a study of 416 pediatric ALL patients, 84% of patients or their parents said the patients took more 6-mercaptopurine (6MP) than they actually did. 6MP is prescribed for 2 years after chemotherapy... [Read Article]

Syringes recalled due to infection risk



Burkholderia_cepacia_CDC_janice-carr-220.jpg
Burkholderia cepacia
Image courtesy of
CDC/Janice Carr

The US Food and Drug Administration (FDA) has announced a Class I, nationwide recall of Nurse Assist Inc.’s normal saline flush syringes due to incidents of Burkholderia cepacia contamination. Nurse Assist reported that patients developed B cepacia bloodstream infections while receiving intravenous care using the... [Read Article]

Study supports palliative care in HSCT recipients



HSCs_being_prepared_for_transplant_credit_Chad_McNeeley_230.jpg
Preparing for HSCT
Photo by Chad McNeeley

Palliative care can be beneficial for patients undergoing hematopoietic stem cell transplant (HSCT) to treat hematologic malignancies, according to research published in em>JAMA. The single-center study suggested that palliative care can improve HSCT recipients’ quality of life, relieve symptoms associated with the procedure, and reduce depression and anxiety.... [Read Article]